Infosys and Old National Bank forged digital transformation partnership.
Dilip Buildcon declared as L-1 bidder by the National Highways Authority of India for a project worth Rs882cr on a Hybrid Annuity basis in the state of Gujarat.
CARE has reaffirmed its rating on Havells India long term bank facilities (CC) at CARE AAA and reaffirmed CARE A1+ to the short term bank facilities.
Tejas Network board meeting will be held on July 27, 2020, to consider and approve the unaudited standalone financial results of the company for the quarter ended June 30, 2020.
Franklin Templeton says it has received full value of principal along with interest of 8.25% on Vodafone Idea's bonds.
The competition commission of India has approved the acquisition of 9.09% stake in Escorts by Kubota Corporation and of 40% in Kubota Agricultural Machinery India by Escorts.
Punjab National Bank clarifies that the provision for the Rs3,688cr fraud in DHFL's NPA account is Rs1,695.7cr instead of Rs1,246.6cr.
Biocon gets DGCI approval to market Itolizumab injection solution for emergency use in India in moderate to severe Covid-19 patients suffering from Cytokine Release Syndrome.
BASF India Board approves acquisition of 100% stake in BASF Performance Polyamides from BASF Nederland B.V. and BASF SE, for a consideration not exceeding Rs 305 crore.
Shriram EPC Board approves issuance and allotment of equity shares worth Rs250cr via preferential issue to Markab Capital, subject to satisfactory completion of due diligence and definitive agreements.
Coromandel International executes Share Purchase Agreement (SPA) for acquisition of 50 lakh equity shares of Rs 10 each of the total share capital of Coromandel SQM (India), a JV between the company and Soquimich European Holdings.
IRB Infra emerges as preferred bidder for Rs2,193cr BoT project under the Bharatmala Pariyojana in West Bengal.
Thyrocare announces completion of 1 lakh Covid-19 tests and has also started testing for Covid antibodies from June 28, and has done more than 25,000 tests till date.
ICRA has re-affirmed the long-term rating on Shalby's term loans and fund-based facilities worth Rs103.02cr of the company's line of credit as ICRA A.
Results today: 5paisa Capital, India Home Loan, Kwality Pharmaceuticals, MBL Infrastructures.